Physician profile
Eric M Crespo
NPI 1841302064
$10,045.18
in general payments reported to CMS, 2019-2025
12 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,095 · 2020: $48.32 · 2021: $141 · 2022: $592 · 2023: $248 · 2024: $2,689 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,841 · Food and Beverage: $1,257 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,840.95 |
| Food and Beverage | $1,257.20 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $6,068.63 | 2019-2020 | |
| Medtronic, INC. | $3,127.34 | 2021-2025 | Evera Mri Xt Dr Surescan, Pulseselect, Cobalt Dr Mri Surescan |
| Cardiva Medical, INC. | $211.06 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $148.29 | 2024 | |
| Abbott Laboratories | $141.05 | 2019-2023 | Merlin@Home |
| Biosense Webster, INC. | $114.65 | 2021-2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $99.95 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $60.79 | 2024 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $21.03 | 2022 | |
| Preventice Services, LLC | $20.57 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.54 | 2019 | |
| Pfizer INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Crespo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.